title: Lessons learned after the withdrawal of rofecoxib.
authors.affiliation: Department of Pharmacy Practice.
authors.forename: Diane
authors.initials: D
authors.lastname: Giaquinta
mesh_terms: D002986:Clinical Trials as Topic; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D003659:Decision Making, Organizational; D006801:Humans; D007783:Lactones / Q000009:adverse effects*; D009203:Myocardial Infarction / Q000139:chemically induced; D012307:Risk Factors; D020521:Stroke / Q000139:chemically induced; D013450:Sulfones / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib